Skip to content

Author

D. van Luong

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical outcomes by type of surgery with perioperative durvalumab in patients with resectable non-small cell lung cancer.

Clinical benefit with perioperative durvalumab plus neoadjuvant chemotherapy plus durvalumab or placebo before surgery followed by adjuvant durvalumab or placebo was generally maintained across the surgery subgroups.

David H. Harpole, J. Heymach, M. Reck et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.